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Abstract: Attention deﬁ  cit hyperactivity disorder (ADHD) is one of the most prevalent 
childhood-onset psychiatric syndromes affecting 5%–10% of school-age children worldwide. 
Distortions in the catecholaminergic system seem to be responsible for this condition. Within 
this system there are several candidate genes, the dopamine receptor D4 (DRD4) and the 
dopamine transporter 1 (DAT1), with common polymorphism which might be associated 
with ADHD. We performed a family based association study with 36 trios and 19 parent 
proband pairs. All diagnoses were conﬁ  rmed by the “Hypescheme” diagnostic computer 
program. In this study we did not observe an association of ADHD with DRD4 and DAT1 
polymorphism neither by the haplotype relative risk (HRR) method nor by the transmission 
disequilibrium test (TdT) method. The odds ratio for the DRD4 7-allele was 1.01 and 0.94 
for both statistical tests, respectively, and the respective odds ratio for the DAT1 6-allele 
were 0.91 and 0.88.
Keywords: ADHD, dopamine receptor D4, dopamine transporter, haplotype relative risk, 
transmission disequilibrium test
Introduction
Attention deﬁ  cit hyperactivity disorder (ADHD) is a rather common (5%–10%) 
(Burd et al 2003) psychiatric disorder in schoolchildren between the age of six to ten 
years. The details of the etiology and pathophysiology of this disorder have still to 
be worked out, but available data implicate a dysregulation of the catecholaminergic 
system and this malfunction might be effected by polymorphisms of several genes 
involved in this system (Kronenberg et al 1999; Faraone et al 2001). Twin studies have 
demonstrated a high degree of heredity (0.6–0.9) in this disorder (Todd et al 2005). 
Molecular genetic studies of ADHD have focused on genes in catecholaminergic 
pathways because animal models, theoretical considerations, and the effectiveness of 
stimulant treatment implicate catecholaminergic dysfunction in the pathophysiology 
of the disorder (Faraone et al 2001).
Candidate genes for association and linkage studies are those involved in the 
dopamine pathway like the dopamine receptor D4 (DRD4) and the dopamine transporter 
1 (DAT1) genes. Numerous molecular genetic studies have been conducted with 
ambiguous ﬁ  ndings. These studies were lately used for two meta-analyses to increase 
the statistical power of the ﬁ  ndings (Kronenberg et al 1999; Maher et al 2002; Menzel 
2003; Todd et al 2005).Neuropsychiatric Disease and Treatment 2008:4(4) 702
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Most of these studies have been almost exclusively 
conducted in North America and none were conducted 
in central Europe during the last eight years. We decided 
to recruit patients with ADHD in southern Germany and 
the western part of Austria. To increase the comparabil-
ity of the diagnosis we used a computer-based diagnostic 
scheme for evaluation of all diagnosis. This computer 
program was developed by Sarah Curran and colleagues 
at the Institute of Psychiatry, London, United Kingdom 
under the name “Hypescheme” and can be downloaded 
from the following webpage http://iop.kcl.av.uk/IoP/
Departments/SGDPsy/Hypescheme.shtml (Curran et al 
2000) and is closely related to the Conner’s rating system 
(Conners et al 1998).
The hyperactive patients were recruited in three different 
locations. To circumvent problems of stratiﬁ  cation due to 
differences in ethnic background, we choose to perform a 
family based study (Ewens and Spielman 1995; Todd 2000). 
Children with diagnosed ADHD were recruited together 
with their parents.
In the present paper the diagnosis of attention deﬁ  cit 
hyperactivity disorder was evaluated with the “Hypescheme” 
program. The patients with ADHD and their parents were 
analyzed for the repeat polymorphism in the DRD4 (48bp-
repeat) and the DAT1 (3’-40bp repeat) genes. Statistical 
analysis was performed by the haplotype relative risk (HRR) 
and the transmission disequilibrium test (TDT) methods 
(Ewens and Spielman 1995; Todd 2000). To also include 
pairs (1 affected child and one parent), the possible genotype 
of the missing parent was reconstructed and added to the 
analysis after weighting the genotypes according to occur-
rences in the normal population (Doucette-Stamm et al 1995; 
Kustanovich et al 2003).
Methods
Patient recruitment and diagnosis 
evaluation
Patients and their parents were recruited at institutions spe-
cialized in diagnosis and treatment of children with ADHD. 
These institutions were located in Innsbruck and Salzburg, 
Austria and Böblingen, Germany. In order to standardize 
the diagnosis, all patients were evaluated with the “Hype-
scheme” program after its release in 2000. Also children 
with other or no psychiatric disorders were diagnosed with 
the “Hypescheme” program to evaluate this program with 
respect to false – positive results. All parents gave informed 
consent for this study.
DNA isolation
DNA was isolated from 5–10 ml of EDTA-blood. First, 
erythrocyte-lysis puffer (155 mM NH4CL, 10 mM KHCO3) 
was added to the blood (10 to1 v/v) and left for 30 min 
on ice. After centrifugation at 3000 g for 15 min the 
pellet was washed with erythrocyte-lysis puffer and the 
centrifugation was repeated. Only the tightly precipitated 
pellet was used. The pellet was solubilized with 10x Taq-
polymerase buffer (0.5 M KCl, 0.1M Tris-HCl pH 9.0 and 
15 mM MgCl2), 2% Triton X-100 and 0.2 mg/ml Pronase 
A (Roche, Switzerland). This solution was about 1/10 of 
the whole blood volume and incubated for 3 h at 55 °C. 
After an inactivation at 95 °C for 15 min, the solution was 
vortexed, placed immediately on ice, and Pefabloc (Roche, 
Switzerland) was added at a ﬁ  nal concentration of 0.1% 
and the solution was kept at 4 °C and used for polymerase 
chain reaction (PCR).
PCR of DRD4 and the DAT1 
polymorphism
PCR for the DRD4 polymorphism was done according 
to Nanko and colleagues (1993) with some modiﬁ  cation. 
Dimethylsulfoxide was omitted and we used “Hot start”-
Taq polymerase with Q-solution from Quiagen (Quiagen, 
Valencia, USA). The 200 μmol/L of deazaguanosine was 
replaced by 100 μmol/L deazaguanosine and 100 μmol/L 
guanosine. Electrophoresis of the PCR-fragments was run 
on a 4% Metaphor® gel (BMA Bioproducts, Rockland USA). 
PCR for the DAT1 polymorphism was performed according 
to Doucette-Stamm and colleagues (1995).
Table 1a Allele count for the haplotype relative risk calculation 
of the DRD4 polymorphism of the 36 Trios and 13 Duos
 Alleles
 7  others
Cases 19  79
“controls” 19,4 79,6
Statistics: OD = 1.01 (95% CI 0.47–2.18) p = 1.0.
Table 1 Allele count for the haplotype relative risk calculation 
of the DRD4 polymorphism of the 36 Trios
 Alleles
  2  3 4  6 7  8
Cases  10 7 43 1 11 −
“controls” 5  3 50 − 12 2
Statistics: Allele 7 against all others: OD 0.93 (95% CI 0.35–2.47) p = 0.88.Neuropsychiatric Disease and Treatment 2008:4(4) 703
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Statistical analysis
For the statistical evaluation of our data we used two 
different approaches. One was the HRR estimation 
(Terwilliger and Ott 1992) and the other was the TDT 
(Ewens et al 1995).
For HRR, we counted all alleles that were passed 
to the patient in each trio and assigned them to the “cases” 
group whereas the untransmitted alleles were assigned 
to the “control” group. All alleles were counted also 
for homozygous parents. These numbers can be analyzed 
by 2 × 2 contingency tables for odds ratio and signiﬁ  cant 
differences.
For the TDT, only the alleles of the informative trios 
were counted for transmission (T) or no-transmission (NT). 
Noninformative cases were omitted. To test if one allele is 
signiﬁ  cantly more transmitted, the following formula is used: 
(T-NT)2/T+NT = χ2 (McNemar-test). To calculate the odds 
ratio in a 2 × 2 contingency table the T and NT values were 
placed in the ﬁ  rst row and the value for (T+NT)/2 twice in 
the second row.
Results
Evaluation of the “Hypescheme” program
We have recruited 43 male and 6 female Caucasian patients 
(6–13 years, mean 8.4, SD 2.2) in three centres (Innsbruck, 
Salzburg, and Böblingen) encompassing 36 trios (parents and 
child) and 13 pairs (one parent and child). All children had 
ADHD according to the DSM-IV criteria. 10 suffered from 
additional conduct disorders and 5 from learning disorders. 
Other psychiatric/psychological disorders such as depression 
or anxiety disorders were deﬁ  ned as exclusion criteria. 
Diagnosis was conﬁ  rmed by the “Hypescheme” program 
(16 attention deﬁ  cits, 4 hyperactive, and 29 combined). 
The sensitivity and speciﬁ  city of the “Hypescheme” program 
are both 1.0 according to DSM-IV criteria. The diagnostic 
algorithm of the program identiﬁ  es hyperactive children 
with a speciﬁ  ty of 1.0 (sensitivity 0.33) according to ICD-10 
criteria (Menzel 2003).
Dopamine receptor D4 polymorphism 
and ADHD
The analysis of our sample of parents and children with 
ADHD demonstrated the existence of six different alleles 
in the DRD4 gene. We observed 2, 3, 4, 6, 7, and 8 
alleles according to the nomenclature of van Tol and col-
leagues (1992). None of these was signiﬁ  cantly associated 
with ADHD in the 36 trios, neither by the haplotype 
relative risk nor by the transmission disequilibrium test 
(Table 1 and 2). When the “risk” allele (number 7 allele) was 
compared with the other alleles, a nonsigniﬁ  cant (p = 0.88) 
odds ratio of 0.93 (95% CI 0.35–2.47) by the HRR method 
and a χ2 = 0.04 (odds ratio = 0.92; 95% CI 0.24–3.47) by 
the TDT method was obtained. If the 13 pairs were added to the 
calculation, similar results were observed (Table 1a and 2a).
Dopamine transporter 1 polymorphism 
and ADHD
The examination of our sample of parents and children 
with ADHD exhibited three different alleles of the DAT1 
Table 2 Allele count for the transmission disequilibrium test 
of the DRD4 polymorphism of the 36 Trios
 Not  transmitted
    2 3 4 6  7 8
transmitted 2     7   2
  3     7   1
  4 6 1     8 2
  6       1
  7 2   9  
  8      
Statistics: Allele 7 against all others: χ2 = 0.04 OD = 0.92 (95% CI 0.24–3.47).
Table 2a Allele count for the transmission disequilibrium test 
of the DRD4 polymorphism of the 36 Trios and the 13 Duos
 Not  transmitted
   7  others
transmitted 7    18,15
 others  17,125 
Statistics: χ2 = 0.04 OD = 0.94 (95% CI 0.33–2.70).
Table 3 Allele count for the haplotype relative risk calculation 
of the DAT1 polymorphism of the 36 Trios
 Alleles
 5  6  7
Cases 16 56 
“controls” 14  56 2
Statistics: Allele 6 against all others: χ2 = 0.0 OD = 1.0 (95% CI 0.42–2.35).
Table 3a Allele count for the haplotype relative risk calculation 
of the DAT1 polymorphism of the 36 Trios and 13 Duos
 Alleles
 5  6  7
Cases 24 73 
“controls” 20,6  75,4 2
Statistics: Allele 6 against all others: χ2 = 0.04 OD = 0.91 (95% CI 0.46–1.89).Neuropsychiatric Disease and Treatment 2008:4(4) 704
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gene which were designated 5, 6, and 7 according to the 
nomenclature of Doucette-Stamm and colleagues (1995). 
We did not observe any signiﬁ  cant association with ADHD 
in the 36 trios, neither by the haplotype relative risk nor 
by the transmission disequilibrium test (Table 3 and 4). 
Comparison of the “risk” allele (number 6 allele) with 
the other alleles gave a nonsignificant result. An odds 
ratio of 1.0 (95% CI 0.42–2.35) (p = 0.0) was obtained by 
the HRR method and a χ2 = 0.0 (odds ratio = 1.0; 95% CI 
0.31–3.25) was obtained by the TDT method. If the 13 pairs 
were added to the calculation, similar results were observed 
(Table 3a and 4a).
Discussion
We present a study that is the ﬁ  rst to use the computer-based 
program, “Hypescheme”, which is based on DSM-IV for 
diagnosis of ADHD. It is also the ﬁ  rst that is conducted with 
a sample from central Europe.
Using the “Hypescheme” computer program to diag-
nose ADHD introduces a new diagnostic tool that shows 
high sensitivity and speciﬁ  ty. Since it can be used by other 
investigators in the same way, it might be a good tool to 
standardize the diagnosis of ADHD.
This study does not support the previous ﬁ  ndings of an 
association between the DRD4 7-allele and the DAT1 6-allele 
and ADHD.
Two meta-analyses (Kronenberg et al 1999; Menzel 
2003) have only come up with a signiﬁ  cant association 
when several studies were combined, although the odds 
ratios were not very different from 1.00. Meta-analyses are 
always prone to publication bias. Although one publication 
(Kronenberg et al 1999) claims to have checked for this 
bias with the method published by Egger and colleagues 
(1997) the later method has not been mathematically 
correctly applied.
Just recently a new publication (Li et al 2006) has been 
issued from a group that has formerly observed a positive 
association with the DRD4 polymorphism and was included 
in the meta-analyses (Kronenberg et al 1999; Menzel 
2003). Now in a larger sample they no longer detect this 
association and also found no association with the DAT1 
polymorphism.
It is very important to publish all results from association 
studies regardless as to whether they reveal positive, negative, 
or no association at all.
Limitations
Although we have to admit that our study is quite small (36 
trios and 13 pairs), it ﬁ  ts into the general picture that only a 
very few publications have been able to demonstrate: a sig-
niﬁ  cant association of these alleles with ADHD (Kronenberg 
et al 1999; Menzel 2003).
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